Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 0 results

Early research (Phase 1)Study completedNCT04666649
What this trial is testing

Pegcrisantaspase in Combination With Venetoclax for Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)

Who this might be right for
Relapsed or Refractory Acute Myeloid Leukemia
University of Maryland, Baltimore 27
Early research (Phase 1)Study completedNCT05564650
What this trial is testing

Navitoclax in Relapsed or Refractory High-Risk Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic SyndromeRecurrent Myelodysplastic SyndromeRefractory Myelodysplastic Syndrome
Thomas Jefferson University 6
Large-scale testing (Phase 3)Ended earlyNCT05054543
What this trial is testing

Study to Evaluate the Efficacy of Uproleselan in Combination With Chemotherapy in Chinese Patients With R/R AML

Who this might be right for
Relapsed/Refractory AML
Apollomics Inc. 140
Not applicableUnknownNCT05734898
What this trial is testing

NKG2D CAR-NK & r/rAML

Who this might be right for
AML
Zhejiang University 30
Early research (Phase 1)Looking for participantsNCT06835140
What this trial is testing

CD123-CD16-NK Cells Immunotherapy for AML

Who this might be right for
AML (Acute Myelogenous Leukemia)NK CellCD123+ Acute Myeloid Leukemia
Chunji Gao 9
Early research (Phase 1)Looking for participantsNCT07384715
What this trial is testing

First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS)

Who this might be right for
R/R AMLR/R HR-MDSAcute Myeloid Leukemia+1 more
Genmab 78
Testing effectiveness (Phase 2)Study completedNCT03417154
What this trial is testing

Nivolumab and Oral Cyclophosphamide for R/R AML and HIgh Risk MDS

Who this might be right for
Acute Myeloid LeukemiaHigher Risk Myelodysplastic Syndrome
Masonic Cancer Center, University of Minnesota 12
Early research (Phase 1)Active Not RecruitingNCT05546580
What this trial is testing

Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+)

Who this might be right for
Acute Myeloid Leukemia, in RelapseAcute Myeloid Leukemia Refractory
Oryzon Genomics S.A. 50
Early research (Phase 1)Study completedNCT04839341
What this trial is testing

Study to Evaluate PK and Safety With Uproleselan Combined With Chemotherapy to Treat Chinese R/R AML Patients

Who this might be right for
Relapsed/Refractory AML
Apollomics Inc. 12
Testing effectiveness (Phase 2)Looking for participantsNCT05305859
What this trial is testing

Venetoclax Combining Chidamide and Azacitidine (VCA) in the Treatment of R/R AML

Who this might be right for
Leukemia, Myeloid, AcuteRelapsed Adult AMLRefractory Leukemia
The First Affiliated Hospital of Xiamen University 30
Early research (Phase 1)UnknownNCT05471323
What this trial is testing

Phase I Clinical Trial of RC1012 Injection in Patients With r/r AML

Who this might be right for
Acute Myeloid Leukemia
Guangdong Ruishun Biotech Co., Ltd 36